Spindle cell lipoma: a diagnostic pitfall in technetium-99m methoxyisobutyl isonitrile parathyroid scintigraphy [0.03%]
99mTc-MIBI甲状旁腺扫描的诊断陷阱——脂肪脊椎细胞瘤
Olgierd Chrabański,Magdalena Londzin-Olesik,Jacek Pająk et al.
Olgierd Chrabański et al.
A dozen decades in the service of internal medicine: Polish Society of Internal Medicine 1906-2026 [0.03%]
内科医学一百二十年的贡献：波兰内科医学协会1906-2026
Eugeniusz Kucharz,Anetta Undas
Eugeniusz Kucharz
Rethinking ambulatory blood pressure monitoring: blood pressure variability as a window into frailty and aging [0.03%]
重新思考门诊血压监测：通过血压波动了解衰弱和衰老
Michihiro Satoh,Hiroki Nobayashi,Shingo Nakayama
Michihiro Satoh
Lowering the bar? Noninvasive tests for identifying significant fibrosis in metabolic dysfunction-associated steatotic liver disease [0.03%]
代谢功能障碍相关肝脂肪变性肝病患者严重纤维化的非侵入式检测标志物评估
Michael Pavlides,Erica Appiah
Michael Pavlides
Serum copper and high-risk plaque: a promising finding that still requires clinical validation [0.03%]
血清铜和高危斑块：一项有前景的发现，但仍需临床验证
Andrea Denegri,Michal Pruc,Lukasz Szarpak
Andrea Denegri
Long-term outcomes of sirolimus therapy in sporadic and tuberous sclerosis complex-associated lymphangioleiomyomatosis: a retrospective cohort study [0.03%]
西罗莫司治疗特发性和结节性硬化症相关淋巴管肌瘤病的长期疗效：回顾性队列研究
Joanna Nowacka-Ejsmont,Karol Bączek,Iwona Bestry et al.
Joanna Nowacka-Ejsmont et al.
Introduction: Sirolimus is the standard disease-modifying therapy for lymphangioleiomyomatosis (LAM), but long-term routine-care data integrating pulmonary, lymphatic, extrapulmonary, and biomarker outcomes remain limite...
Long-term follow-up after successful multi-stage intravascular repair of acute aortic dissection associated with cocaine exposure [0.03%]
长期随访成功治疗与可卡因使用相关的急性主动脉夹层患者的效果
Rafał Maciąg,Ignacy Sterliński,Zbigniew Gałązka et al.
Rafał Maciąg et al.
Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke [0.03%]
老年合并症患者房颤的直接口服抗凝药：脆弱性，肾损害，急性或慢性冠状动脉综合征和急性卒中的作用
Felicita Andreotti,Adhithya N Balaji,Luigi Cappannoli et al.
Felicita Andreotti et al.
Direct oral anticoagulants (DOACs) have been available since 2008, boosting appropriate anticoagulation and reducing intracranial hemorrhages compared to warfarin therapy. For older patients with atrial fibrillation (AF) and comorbidities, ...